RGEN FY2025 SEC EDGAR DEF 14A #51 of 168 in industry

Repligen Corp CEO pay ratio

The CEO earned $6.1M in FY2025 against median worker pay of $74,954 · Chemicals & Pharmaceuticals.

Chemicals & Pharmaceuticals peers All rankings
State
DE
Filing date
2026-04-02
Industry
Chemicals & Pharmaceuticals
Industry rank
#51/168

Data updated August 2026

Subscribe to Repligen Corp CEO pay filing updates (RSS)

CEO-to-worker pay ratio
82:1
Moderate (Scale: 0–1000:1)
CEO pay
$6.1M
Median worker
$74,954

Answer first

Repligen Corp's FY2025 CEO total of $6.1M ranks #839 of 1,423 complete filings; its 82:1 pay ratio ranks #755. Dollar rank is not ratio rank.

According to the same FY2025 complete-filing cohort used on the rankings boards (CEO total, median worker, and ratio all present). Median worker pay is $74,954. Industry placement uses the FY2025 SIC-28 peer cohort (# 51 of 168, 70th percentile - above the industry median pay ratio). Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.

Dollar rank
#839
$6.1M of 1,423 FY2025
Ratio rank
#755
82:1 of 1,423
Industry pct
70th
above the industry median pay ratio

How Repligen Corp ranks nationally

Repligen Corp CEO pay vs. every FY2025 complete filing

Total CEO compensation, the full national distribution, this company marked

$6,114,771 41st percentile higher than 41% of 1,423 companies

$0–$2,500,000: 304 companies (21%). Below this entry. $2,500,000–$5,000,000: 182 companies (13%). Below this entry. $5,000,000–$7,500,000: 208 companies (15%). This entry sits in this band. $7,500,000–$10,000,000: 192 companies (13%). Above this entry. $10,000,000–$12,500,000: 139 companies (10%). Above this entry. $12,500,000–$15,000,000: 91 companies (6%). Above this entry. $15,000,000–$17,500,000: 88 companies (6%). Above this entry. $17,500,000–$20,000,000: 54 companies (4%). Above this entry. $20,000,000–$22,500,000: 24 companies (2%). Above this entry. $22,500,000–$25,000,000: 34 companies (2%). Above this entry. $25,000,000–$27,500,000: 24 companies (2%). Above this entry. $27,500,000–$30,000,000: 16 companies (1%). Above this entry. $30,000,000–$32,500,000: 10 companies (1%). Above this entry. $32,500,000–$35,000,000: 7 companies (0%). Above this entry. $35,000,000–$37,500,000: 9 companies (1%). Above this entry. $37,500,000–$40,000,000: 6 companies (0%). Above this entry. $40,000,000–$42,500,000: 1 companies (0%). Above this entry. $42,500,000–$45,000,000: 1 companies (0%). Above this entry. $45,000,000–$47,500,000: 6 companies (0%). Above this entry. $47,500,000–$50,000,000: 27 companies (2%). Above this entry. This company $0 $50M+ every complete-filing company, bucketed by value

Each bar is a $2500K-wide band; taller bars hold more companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source SEC DEF 14A Section 953(b) disclosures, PlainCEOPay extract · FY2025

Repligen Corp vs. Chemicals & Pharmaceuticals peers

CEO total pay ($6.1M) against pay ratio (82:1) for Repligen Corp (marked) and its 5 closest same-industry peers, against the Chemicals & Pharmaceuticals industry median on both axes.

Pay + gap both highContained pay, wide gapHigh pay, contained gapBelow peer norms on both3477847.28104765.11273168317358600.921985518.839.9:151.7:163.5:175.3:187.2:1CEO total payPay ratio (CEO : median worker)Repligen Corp, CEO total pay: 6114771 · Pay ratio (CEO : median worker): 82:1Repligen CorpSupernus Pharmaceuticals, Inc., CEO total pay: 15501556 · Pay ratio (CEO : median worker): 81:1Supernus Pharmaceuticals, Inc.Vertex Pharmaceuticals Inc / Ma, CEO total pay: 21144261 · Pay ratio (CEO : median worker): 80:1Vertex Pharmaceuticals Inc / MaAvient Corp, CEO total pay: 5818257 · Pay ratio (CEO : median worker): 85:1Avient CorpLantheus Holdings, Inc., CEO total pay: 15346066 · Pay ratio (CEO : median worker): 79:1Lantheus Holdings, Inc.Usana Health Sciences Inc, CEO total pay: 4319105 · Pay ratio (CEO : median worker): 85:1Usana Health Sciences Inc
Repligen Corp vs. Chemicals & Pharmaceuticals peers, plotted against the industry's $7.9M median CEO total and 42:1 median pay ratio.

Ratio bands among Chemicals & Pharmaceuticals peers

Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.

CEO Compensation Breakdown, FY2025

A component-level pay breakdown is not reported in Repligen Corp's structured SEC pay-ratio disclosure. See our methodology →

Filing-year trail · Repligen Corp

Complete DEF 14A pay-ratio filings for this CIK across FY2021–2025. Year-over-year deltas compare adjacent filing years only; incomplete dollar rows are omitted (same completeness gate as the hero figures).

Latest ratio
82:1
FY2025
vs prior FY
+13:1
from FY2024 69:1
CEO $ YoY
-15%
$6.1M latest
Filings shown
5
FY2021–2025
Repligen Corp CEO total compensation, median worker pay, and pay ratio by fiscal year from SEC EDGAR DEF 14A.
FY CEO pay Δ pay Median worker Pay ratio Δ ratio
2021 $7.7M - $115,218 67:1 -
2022 $7.7M -0.6% $84,363 91:1 +24:1
2023 $7.9M +3.3% $101,630 78:1 -13:1
2024 $7.2M -9.2% $104,324 69:1 -9:1
2025 $6.1M -15% $74,954 82:1 +13:1

Source: SEC EDGAR DEF 14A pay-ratio disclosures for CIK 730272, FY2021–2025. Adjacent-year deltas only.

Industry Comparison - Chemicals & Pharmaceuticals

This Company's Ratio
82:1
Industry Median Ratio
42:1
Industry Median CEO Pay
$7.9M
This CEO's Pay
$6.1M
Companies in Industry
168
vs. Industry Median
Above
#51 of 168 by pay ratio in this industry View all companies in Chemicals & Pharmaceuticals →

Repligen Corp: MID · HEAVY pay ratio

Repligen Corp's FY2025 ratio 82:1 ranks #51 of 168 Chemicals & Pharmaceuticals filers (70th percentile). the CEO earned 82× the median employee ($74,954) in FY2025.

Median employee $74,954 (HIGH-MED); MID · HEAVY stamps put about 82 median-wage years per CEO year.

CEO Total Pay

$6.1M

FY2025 Summary Compensation, below median

Pay Ratio

82:1

Near industry median

Repligen Corp in the higher Chemicals & Pharmaceuticals third

Repligen Corp's FY2025 ratio 82:1 ranks #51 of 168 Chemicals & Pharmaceuticals filers (70th percentile). The structured pay-ratio disclosure reports the total without line-item components. Chemicals & Pharmaceuticals (SIC 28) median ratio is 42:1 across 168 FY2025 filers; Repligen Corp's $6.1M CEO total is at or below the $7.9M industry median CEO pay.

Dollar rank #839 and ratio rank #755 split - treat 82:1 as a disclosure, not a fairness score. Open Chemicals & Pharmaceuticals peers.

Key Data, FY2025

Total Compensation
$6.1M
Median Employee Pay
$74,954
Pay Ratio
82:1
Filing Date
2026-04-02

Company Info

Ticker
RGEN
CIK
730272
Industry
Chemicals & Pharmaceuticals
SIC Code
2836
State
DE
View SEC filings →
SEC EDGAR DEF 14A for CIK 730272, FY2025. Informational only, not investment advice. Verify on EDGAR.

Read our methodology - how this data is sourced, computed, and verified. Repligen Corp's FY2025 ratio 82:1 ranks #51 of 168 Chemicals & Pharmaceuticals filers (70th percentile).

Read with Repligen Corp

ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps MID · HEAVY · HIGH-MED.

Redwood Trust Inc · HEAVY

ABS(ceo_total_comp) peer at $6.1M (Δ $27K lighter vs Repligen Corp); MODEST · ELITE-MED vs this page's MID · HEAVY · HIGH-MED.
Surgery Partners, Inc. · HEAVY

ABS(ceo_total_comp) peer at $6.1M (Δ $31K lighter vs Repligen Corp); MID · PAR-MED vs this page's MID · HEAVY · HIGH-MED.
Zeta Global Holdings Corp. · HEAVY

ABS(ceo_total_comp) peer at $6.1M (Δ $32K lighter vs Repligen Corp); MODEST · HIGH-MED vs this page's MID · HEAVY · HIGH-MED.
DANA Inc · HEAVY

ABS(ceo_total_comp) peer at $6.1M (Δ $36K lighter vs Repligen Corp); MID · PAR-MED vs this page's MID · HEAVY · HIGH-MED.
Supernus Pharmaceuticals, Inc. (SIC 28 pole)

Supernus Pharmaceuticals, Inc. stamps MID · PEAK nearest in-SIC by ABS(pay_ratio) to Repligen Corp's MID filing.
National dual ranks · #839/#755

Repligen Corp's FY2025 package sits #839 by CEO dollars and #755 by ratio under HEAVY · MID.
Comp structure · HEAVY

Repligen Corp's HEAVY CEO total is equity-sensitive - read what grant-date fair value does and does not mean.
Data sourced from SEC EDGAR DEF 14A for Repligen Corp (CIK 730272), FY2025. See our methodology. Aggregated by PlainCEOPay as of August 2026.

Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.